Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation
Feb 11, 2014

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...

Feb 6, 2014

Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...

Feb 4, 2014

Illumina recently announced the $1000 solution for the sequencing of the human genome in the form of its new instrument, the HiSeqX. This system...

Jan 30, 2014

The selection and accumulation of desirable mutations – also known as natural selection – has shaped the living world. The proteins resulting from...

Jan 28, 2014

One major challenge in drug discovery is determining whether a drug is behaving as intended, binding the “right” protein, inhibiting the correct...

Jan 23, 2014

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast amount...

Jan 21, 2014

Incretins are hormones that the body uses to stimulate insulin release when nutrients are ingested. The two that are the most well-studied are...

Jan 16, 2014

This is Part 2 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 3). Recent medical technology...

Jan 14, 2014

So how does the pharmaceutical industry restore its jaded public image? The answer is by changing itself from within, by paying more than just lip...

Jan 9, 2014

This is Part 1 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 2 and Part 3). Medical research and...